NCT04319731View on ClinicalTrials.gov

A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 20, 2020

Primary Completion Date

June 9, 2020

Study Completion Date

June 9, 2020

Conditions
SARS CoV-2 Infection
Interventions
BIOLOGICAL

Human Amniotic Fluid

Administration of amniotic fluid in SARS-CoV-2 positive patients

Trial Locations (1)

84132

University of Utah Health, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT04319731 - A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure | Biotech Hunter | Biotech Hunter